The effect of mycophenolate mofetil on primary and secondary treatment of primary glomerulonephritis and lupus nephritis

PAYDAŞ S., KURT C., TAŞKAPAN H., BALAL M., SERTDEMİR Y., Pembegul I.

INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.41, sa.1, ss.145-152, 2009 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 41 Sayı: 1
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1007/s11255-008-9454-4
  • Dergi Adı: INTERNATIONAL UROLOGY AND NEPHROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.145-152
  • İnönü Üniversitesi Adresli: Evet

Özet

Mycophenolate mofetil (MMF) has shown to be a reliable choice in the treatment of glomerulonephritis. We retrospectively reviewed the clinical course and response to MMF therapy in 49 patients with primary glomerulopathy (37 patients) and lupus nephritis [class III (five patients) and IV (seven patients)].